Capricor Therapeutics reported $278.7M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Bioline Rx USD 20.83M 2.64M Mar/2026
Capricor Therapeutics USD 278.7M 27.09M Mar/2026
Cipla INR 344.32B 15.13B Mar/2026
Cytokinetics USD -826.57M 166.94M Mar/2026
Geron USD 229.11M 3.24M Mar/2026
Grifols EUR 6.21B 133.12M Dec/2025
Immunic USD 151.23M 157.91M Mar/2026
J&J USD 84.97B 3.78B Jun/2026
Plus Therapeutics USD 11.96M 7.96M Mar/2026
Prothena USD 312.62M 32.14M Mar/2026
PTC Therapeutics USD -180.46M 24.85M Mar/2026
Sarepta Therapeutics USD 1.51B 364.48M Mar/2026